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Summary
Nosocomial infections with coagulase-negative staphylococci (CNS) are an
increasing problem in hospitalized patients, especially in those who are
immunocompromised. About 15% of the bacterial strains isolated from blood
cultures are CNS. It is, however, difficult to determine if a CNS isolated from
a blood culture has to be considered as a contaminant or as pertaining to
bacteraemia, a difficulty not yet overcome.
The genus Staplrylococcas is very heterogeneous and currently consists of over
30 species. In some situations, for instance in cases in which bacteraemia plays
a role, it is desirable to know the name of the species. This determination can
be carried out by means of commercial tests. However, these tests are
expensive and lack specificity. About 75Vo of the strains of CNS isolated from
blood cultures is Staplrylococcus epidermidis. With a few simple and
inexpensive tests, desferrioxamine susceptibility and sugar fermentation, this
species can be discriminated from the other CNS (chapter II).
Some strains of CNS, especially Staphylococcus epidermidis again, have the
property to produce extra-cellular slime. Together with other cell components
this substance is able to form a biofilm, for instance on prosthetic devices, in
which bacteria can protect themselves against host defence mechanisms and the
action of antimicrobial agents. We have investigated the possibility to use the
slime producing property for discriminating contaminants from strains isolated
from blood cultures of patients with bacteraemia. There was a significant
difference in the number of slime producing strains between "contaminants" and
strains pertaining to "bacteraemia". However, within the group of
"contaminants" a considerable number of CNS was positive, making the test
less suitable for the above mentioned aim. The slime producing strains in our
investigation were significantly more resistant to cloxacillin, aminoglycosides,
trimethoprim, erythromycin and ciprofloxacin. It is very likely that the slime
producing ability of these strains provides them with an opportunity to escape
from the action of antibiotics, thus increasing the possibility to develop
resistance under the continuous pressure of antimocrobial agents (chapter III).
As mentioned before, the genus Staphylococca.Í accounts for more than 30
species. Furthermore, within a species many types can be distinguished by
means of fingerprinting with pulse-field gel electrophoresis (PFGE). From the
162 strains of CNS recovered from blood cultures pertaining to "bacteraemia"
in a period of three years (1990-1992) 19 strains, all Staphylococcus
epidermidis, were strongly slime positive with an optical density of )1.00 in
the quantitative microtiterplate test with crystal violet (chapter III).
Fingerprinting with PFGE revealed that 14 strains had the same profile. Three
strains had two and one strain had three bands difference and these strains can
be considered as subtypes. Thus, 18 out of 19 strains recovered from blood
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cultures submitted to our laboratory by different departments in a period of
three years, in all likelihood progenated from the same parent strain. Because
of its properties concerning slime production and resistance to antimicrobial
agents the strain was able to give rise to clonal spread throughout the entire
hospital (chapter IV).
Because most of the CNS are resistant to penicillin, the drug of first choice in
cases where bacteraemia with CNS has to be treated, used to be cloxacillin, a
small spectrum anti-staphylococcal agent. However, strains of CNS, especially
Staplrylococcus epidermidis, have become more resistant. A cloxacillin resistant
staphylococcus has to be considered resistant to all penicillins, cephalosporins
and carbapenems. This causes the physician to prescribe an agent like
vancomycin, an expensive drug with considerable side-effects. Thus it is
important to know, in a fast and reliable way, the susceptibility of a strain to
cloxacillin. The best technique to determine this susceptibility is the polymerase
chain reaction @CR). However, many of the routine laboratories do not have
the opportunity to explore this expensive technique and have to rely on more
conventional methods. The conditions for these methods have been under
investigation for many years. The conditions we used in this investigation,
Mueller Hinton Agar with 2% NaCl, a 5 prg oxacillin disk and 24 hours of
incubation at 35oC, yielded a good sensitivity and specificity compared with
PCR (chapter V).
Strains of CNS become more and more resistant in the hospital under the
continuous pressure of the use of antibiotics for therapy and prophylaxis. In
chapter VI the increasing resistance to cloxacillin and aminoglycosides is
demonstrated. In the department of haematology, where ciprofloxacin was used
as a prophylactic agent, there was a rapid development of resistance to this
agent. This was followed by a small recovery, when the prophylactic use of
ciprofl oxacin was diminished.
The results of this investigation are based on laboratory findings. The outcomes
of this study can and should be used for further investigation on CNS in clinical
trials in order to find parameters to discriminate contaminants from strains
associated with bacteraemia, to define epidemiological relevance and to give
directives for antibiotic policy.
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